Juliet Emamaullee MD, PhD FRCSC FACS
University of Southern California
"Temporal Changes in the Immune Landscape During Liver Transplantation Rejection"
Suraj J. Patel, MD, PhD
Beth Israel Deaconess Medical Center, Harvard Medical School
"Role of IRF3 in uncoupling hepatic metabolism in NAFLD"
Ji-Yeon Shin, PhD
"A Novel Nuclear Envelope Mediator of Steatosis and NASH"
Po-Hung Chen, MD
Johns Hopkins University
"The Impacts of Early Liver Transplantation and Sustained Abstinence on the Natural History of Severe Alcoholic Hepatitis – A Survival Benefit Study"
Zhenghui Gordon Jiang, MD, PhD
Beth Israel Deaconess Medical Center
"Targeting Cholesterol Toxicity via Abnormal Lipoproteins in Alcoholic Hepatitis"
Vanessa Leone, PhD
The University of Chicago
"The Role Of Diet-Induced Dysbiosis on Liver Fibrosis in Nonalcoholic Fatty Liver Disease (NAFLD): Identifying Causation And Microbiome-Based Interventional Strategies"
Nataliya Razumilava, MD
University of Michigan
"Utility of Preclinical Organoid Models For Extrahepatic Cholangiocarcinoma Diagnosis And Treatment Assessment"
Adam J. Gehring, PhD
Toronto Centre for Liver Disease University Health Network
"Immunological Response to HBV Reactivation in Patients Stopping Nucleoside Analogue"
Dragana Kopanja, PhD
University of Illinois at Chicago
"Roles of FoxM1 in Hepatic Stellate Cells in Liver Fibrosis and HCC Development"
Michelle T. Long, MD
Boston University School of Medicine
"Determining the Burden, Heritability, and Clinical Implications of Increased Liver Stiffness from Fatty Liver Disease in Older Adults"
Ryan J. Schulze, PhD
"A Novel Autophagic Mechanism Mediating Lipid Droplet Catabolism in Hepatocytes"
Zongdi Feng, PhD
The Ohio State University College of Medicine
“Biogenesis and Functions of Secreted HBV RNA Particles”
Samar Ibrahim, MB, ChB
“Mechanisms of Liver Injury in Nonalcoholic Steatohepatitis”
Daniela Sia, PhD
Icahn School of Medicine at Mount Sinai
“Biomarkers of Response to lmmunotherapy in Liver Cancer”
Qian Xie, MD, PhD
James H. Quillen College of Medicine
East Tennessee State University
“Met-Targeting T Cell Therapy against Hepatocellular Carcinoma”
Jaime Chu, MD
Icahn School of Medicine at Mount Sanai
“Protein Glycosylation as a Novel Cellular Regulator of Hepatic Fibrosis”
Joanne Hsieh, PhD
College of Physicians and Surgeons of Columbia University
“Hepatoprotective Mechanisms in TTC39B Deficiency”
Genta Kakiyama, PhD
Virginia Commonwealth University
“Elucidation of the Oxysterol Pathway and the Role of CYP71B in the Development of Liver Inflammation and Firbrosis”
Harmeet Malhi, MBBS
Mayo Clinic College of Medicine
“Endoplasmic Reticulum Stress and Sphingolipids in NASH”
Andras Heczey, MD
Baylor College of Medicine
“Immunotherapy of Hepatocellular Carcinoma with Dual Specific Natural Killer T Cells”
Robert Christian Huebert, MD
“Epigenetic Mechanisms of Biliary Regeneration”
Jennifer Layden, MD, PhD
Loyola University Chicago
“HBV Genotype E: Impact on Virologic and Serologic Host Response”
Massimiliano Paganelli, MD, PhD
CHU Sainte-Justine - Universitié de Montreal
“Autologous Transplantation of Induced Pluripotent Stem Cells-Derived Hepatocytes to Treat Hereditary Tyrosinemia Type 1”
Matthew Burchill, PhD
University of Colorado, Denver
“Immune Reconstitution and Reversal of Chronic Exhaustion Following Novel Directly-Acting Antiviral (DAA) Therapy”
Like Engelking, MD, PhD
UT Southwestern Medical Center
“Site-2 Protease and Fatty Liver Disease”
William Osbourn, PhD
Johns Hopkins University
“Pharmacological Targeting of the CCR5 Signaling Pathway to Enhance Anti-Hepatitis B Virus Immune Response”
Dean Yimlamai, MD, PhD
Boston Children's Hospital
“Novel Regulators of Hippo Signaling in Liver Disease”
Akiko Eguchi, PhD
University of California, San Diego
“The Development of Novel Diagnostic and Therapeutic Approaches for Non-Alcoholic Liver Disease Targeting Circulating Microparticles with Specific Antigens and MicroRNA Compositions”
Michel Fausther, PhD
University of Arkansas for Medical Sciences
“Ecto-5’-Nucleotidase/CD73 in the Pathogenesis of Liver Fibrosis”
Guisheng Song, PhD
University of Minnesota
“MicroRNA-206 as a Therapeutic Agent for Hepatocellular Carcinoma by Inhibiting Notch3”